Table 2 Mean dietary intakes of study participants at baseline, weeks 5, 9 and 12 of the study1
From: Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients
|  | Placebo group (n = 30) | Vitamin D plus probiotic group (n = 30) | P2 |
|---|---|---|---|
Energy (kcal/d) | 2540 ± 184 | 2488 ± 147 | 0.23 |
Carbohydrates (g/d) | 347.9 ± 42.1 | 337.9 ± 43.2 | 0.36 |
Protein (g/d) | 89.5 ± 12.9 | 85.7 ± 11.2 | 0.23 |
Fat (g/d) | 92.6 ± 13.4 | 92.2 ± 12.2 | 0.91 |
SFAs (g/d) | 26.4 ± 5.6 | 26.3 ± 5.8 | 0.85 |
PUFAs (g/d) | 30.0 ± 8.4 | 28.9 ± 6.9 | 0.61 |
MUFAs (g/d) | 25.0 ± 5.6 | 24.4 ± 5.8 | 0.68 |
Cholesterol (mg/d) | 188.6 ± 97.0 | 222.6 ± 119.7 | 0.18 |
TDF (g/d) | 20.7 ± 5.2 | 18.9 ± 4.8 | 0.18 |
Magnesium (mg/d) | 325.1 ± 88.3 | 295.8 ± 69.7 | 0.15 |
Zinc (mg/d) | 11.1 ± 3.0 | 10.4 ± 2.8 | 0.34 |
Manganese (mg/d) | 2.4 ± 0.8 | 2.3 ± 0.6 | 0.44 |
Calcium (mg/d) | 1203.1 ± 161.9 | 1145.6 ± 231.3 | 0.27 |
Vitamin D (μg/d) | 2.8 ± 0.7 | 2.6 ± 0.5 | 0.24 |